Invention Grant
- Patent Title: T cell modifying compounds and uses thereof
-
Application No.: US14051244Application Date: 2013-10-10
-
Publication No.: US09597357B2Publication Date: 2017-03-21
- Inventor: Philip D. Gregory , Michael C. Holmes
- Applicant: Sangamo BioSciences, Inc.
- Applicant Address: US CA Richmond
- Assignee: Sangamo BioSciences, Inc.
- Current Assignee: Sangamo BioSciences, Inc.
- Current Assignee Address: US CA Richmond
- Agency: Pasternak Patent Law
- Agent Susan Abrahamson
- Main IPC: A61K35/26
- IPC: A61K35/26 ; C07K16/28 ; C07K16/32 ; A61K35/17
Abstract:
Methods and compositions for modifying T-cells in which PD1 and/or CTLA-4 is repressed and/or inactivated using fusion proteins such as artificial transcription factors and nucleases.
Public/Granted literature
- US20140120622A1 T CELL MODIFYING COMPOUNDS AND USES THEREOF Public/Granted day:2014-05-01
Information query
IPC分类:
